Future Virology. 2015;10(2):77-88. As shown in Figure 2A, katsumadain A exhibited a high level of self-FL at concentrations similar to or greater than 10 µM when compared with the background ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Recent research has provided valuable insights into the susceptibility of influenza viruses to antiviral drugs, particularly neuraminidase inhibitors (NAIs) and the newer polymerase acidic (PA ...

Choreo LLC acquired a new stake in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) during the fourth quarter, according to the company in its most recent filing with the ...

The U.S. Department of Health and Human Services announced contract awards for up to 120,000 treatment courses of intravenous antiviral drugs to help treat hospitalized 2009 H1N1 influenza ...

Antiviral medications such as neuraminidase inhibitors, like oseltamivir (Tamiflu) and zanamivir (Relenza), and endonuclease inhibitors, such as baloxavir (Xofluza), are used to alleviate symptoms ...

Limitations in current antiviral treatments, including resistance to neuraminidase inhibitors, have driven interest in developing polymerase subunit inhibitors, such as baloxavir and the newly ...